In order to generate an optimal preparation of hydrolyzed collagen, Genacol® has developed the AminoLock ® Sequence Technology (AST). The process begins with high quality gelatine obtained from free-range nature-fed cattle. This gelatine is subjected to a well-controlled enzymatic hydrolysis, followed by a desalting procedure (based on ion exchange). The product is then concentrated by evaporation, sterilized and spray dried to produce a fine powder of the best quality.
The average size of commercially available hydrolyzed collagen generally varies between 6 and 10 kDa. In contrast, thanks to the AminoLock® Sequence Technology, the controlled enzymatic hydrolysis process produces peptide fragments of more uniform size, 90% of which are smaller than 2 kDa. Moreover, this technology enables Genacol® to ensure its hydrolyzed collagen contains well-established proportions of key amino acids required to promote collagen production in the body and to give an optimal therapeutic outcome.
In fact, it would take up to 5 to 10 times more of a standard hydrolyzed collagen product to obtain an equivalent concentration of certain amino acids and peptide fragments present in Genacol®'s Derma capsules.
THE SAME BENEFITS
AT FRACTION OF COST
Only 4 Derma
capsules per day
More than 33 capsules
per day of other